| Literature DB >> 30245828 |
S Abbasian1, N N Farahani1, Z Mir1, F Alinejad2, M Haeili3, M Dahmardehei2, M Mirzaii4, S S Khoramrooz5, M J Nasiri6, D Darban-Sarokhalil1.
Abstract
Infections caused by Staphylococcus aureus remain a major global healthcare problem. We aimed to find the common lineages of S. aureus strains circulating in a burn hospital in Tehran. A total of 167 isolates of S. aureus obtained from patients, healthcare workers (HCWs) and environment in Shahid Motahari burn hospital were genotyped by using spa, agr and staphylococcal cassette chromosome mec (SCCmec) typing methods. Antimicrobial susceptibility testing was performed by using the disc diffusion method. The frequency of methicillin-resistant S. aureus (MRSA) was 64.7% (n = 108), with distribution frequencies among patient, HCW and surface isolates of 64.2% (n = 79), 50% (n = 7) and 73.3% (n = 22), respectively. SCCmec type III (75%, n = 81) was found to be the most frequent SCCmec type among MRSA isolates, followed by SCCmec type I (20.4%, n = 22) and SCCmec type IV (1.8%, n = 2). The remaining MRSA isolates (2.8%, n = 3) were nontypeable by this method. About 78.4% (n = 131), 10.2% (n = 17) and 4.8% (n = 8) of all isolates were characterized as agr types I, II and III, respectively, and the other isolates (6.6%) were nontypeable. spa types t030 and t037 constituted the first and second most predominant spa types found in 56.4% (n = 57) and 25.6% (n = 26) of isolates, respectively. We also report here a novel spa type, t16471. The most prevalent genotypes of the isolates found among patient, surface and HCW samples were SCCmec type III/t030, t037/agr type I. Continuous tracking of epidemic isolates and better hospital infection control policies are recommended to efficiently prevent the spread of bacteria to inpatients.Entities:
Keywords: Iran; MRSA; SCCmec typing; agr typing; spa typing
Year: 2018 PMID: 30245828 PMCID: PMC6141672 DOI: 10.1016/j.nmni.2018.08.001
Source DB: PubMed Journal: New Microbes New Infect ISSN: 2052-2975
Frequency of MRSA and MSSA in patients, HCWs and surfaces in Shahid Motahari Hospital
| Characteristic | No. of samples | MRSA | MSSA | Total |
|---|---|---|---|---|
| Patients | 175 | 79 (64.2) | 44 (35.8) | 123 (100) |
| HCWs | 88 | 7 (50) | 7 (50) | 14 (100) |
| Surfaces | 142 | 22 (73.3) | 8 (26.7) | 30 (100) |
| Total | 405 | 108 (64.7) | 59 (35.3) | 167 (100) |
Data are presented as n (%).
HCW, healthcare worker; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible S. aureus.
Results of SCCmec typing among MRSA isolates
| SCC | Patient | HCW | Surface | Total |
|---|---|---|---|---|
| I | 16 (14.8) | 0 | 6 (5.6) | 22 (20.4) |
| III | 58 (53.7) | 7 (6.5) | 16 (14.8) | 81 (75) |
| IV | 2 (1.8) | 0 | 0 | 2 (1.8) |
| Nontypeable | 3 (2.8) | 0 | 0 | 3 (2.8) |
| Total | 79 (73.1) | 7 (6.5) | 22 (20.4) | 108 (100) |
Data are presented as n (%).
HCW, healthcare worker; MRSA, methicillin-resistant Staphylococcus aureus.
Genotyping of Staphylococcus aureus isolates by agr typing method
| Patient | HCW | Surface | Total | |
|---|---|---|---|---|
| I | 94 (56.3) | 13 (7.8) | 24 (14.3) | 131 (78.4) |
| II | 11 (6.6) | 2 (1.2) | 4 (2.4) | 17 (10.2) |
| III | 8 (4.8) | 0 | 0 | 8 (4.8) |
| IV | 0 | 0 | 0 | 0 |
| Negative | 10 (6) | 0 | 1 (0.6) | 11 (6.6) |
| Total (%) | 123 (73.7) | 15 (9) | 29 (17.3) | 167 (100) |
Data are presented as n (%).
HCW, healthcare worker.
Distribution of molecular types and different antibiotic resistant patterns in 101 MRSA isolates
| No. patients | No. HCWs | No. surfaces | SCC | Resistance profile | No. isolates | ||
|---|---|---|---|---|---|---|---|
| t030 (57; 56.4) | 40 | 5 | 12 | III, I | I | GM, MUP, RP, E, CD, T, IM, PG, NOR | 48 |
| NOR | 2 | ||||||
| NOR, SXT, PG | 7 | ||||||
| t037 (26; 25.6) | 23 | 1 | 2 | III, I | I | GM, NOR, SXT, CD, E, PG, IM | 16 |
| RP, MUP, GM, PG | 4 | ||||||
| PG, IM, T, CD, E | 6 | ||||||
| t046 (3; 3) | 3 | 0 | 0 | I | I | E, CD, T, PG, IM, GM, MUP, RP, NOR | 3 |
| t4864 (2; 2) | 2 | 0 | 0 | III | II | IM, PG, SXT, NOR, E, T, GM | 2 |
| t091 (2; 2) | 2 | 0 | 0 | NT, III | II, I | E, CD, T, PG, GM, MUP, SXT | 2 |
| t789 (2; 2) | 2 | 0 | 0 | NT, I | III | C, PG, CD, E | 2 |
| t459 (1; 1), t16471 (1; 1) | 1, 0 | 0, 1 | 0, 0 | I, III | I | GM, MUP, RP, NOR, E, CD, T, PG, IM | 2 |
| t363 (1; 1) | 1 | 0 | 0 | IV | I | MUP, E, PG, IM | 1 |
| t3802 (1; 1), t304 (1; 1) | 1, 1 | 0, 0 | 0, 0 | NT, I | I | PG | 2 |
| t937 (1; 1) | 1 | 0 | 0 | I | II | PG, IM | 1 |
| t230 (1; 1) | 1 | 0 | 0 | IV | I | MUP, PG, IM | 1 |
| t3132 (1; 1), t701 (1; 1) | 0, 1 | 0, 0 | 1, 0 | I, III | II, I | GM, MUP, NOR, E, CD, T, PG, IM | 2 |
C, chloramphenicol; CD, clindamycin; E, erythromycin; GM, gentamycin; IM, imipenem; MRSA, methicillin-resistant Staphylococcus aureus; MUP, mupirocin; NOR, norfloxacin; NT, nontypeable; PG, penicillin; RP, rifampicin; SXT, trimethoprim/sulfamethoxazole; T, tetracycline.